Non-severe |
Pharmacologically predictable reactions |
Nausea, vomiting, diarrhoea, pruritis (without rash), headache |
Beta-lactams |
Use all antibiotics |
Severe |
Encephalitis, renal impairment, tendinopathy |
Cefepime, aminoglycosides, fluoroquinolones |
Only avoid the implicated drug or dose |
Type B adverse drug reactions – immune-mediated |
1 |
IgE-mediated |
Urticaria, angioedema, bronchospasm, anaphylaxis |
Penicillins, cephalosporins |
Avoid implicated drug. Caution with drugs in the same class and structurally related drugs |
2 |
Antibody (usually IgG)-mediated cell destruction |
Haemolytic anaemia, thrombocytopenia, vasculitis |
Penicillins, cephalosporins |
3 |
IgG or IgM and complement |
Fever, rash, arthralgia |
Penicillin, amoxicillin, cefaclor |
4 |
T-cell mediated |
Maculopapular exanthema, drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalised exanthematous pustulosis |
Beta-lactams, glycopeptides, sulfonamides |
Avoid implicated drug, drugs in the same class and structurally related drugs |
Anaphylactoid reactions – non-immune-mediated |
Non-IgE-mediated |
Direct mast-cell stimulation or basophil activation |
Flushing, itching, urticaria, angioedema |
Vancomycin, macrolides, fluoroquinolones |
Manage the reaction, either by slowing the infusion or premedication (with antihistamines or corticosteroids) |